Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.97 | 2.23 |
NAV | ₹15.24 | ₹12.92 |
Fund Started | 07 Sep 2022 | 16 Aug 2023 |
Fund Size | ₹2600.33 Cr | ₹883.96 Cr |
Exit Load | 0.5% for redemption within 90 Days | Exit load of 1%, if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 14.68% | 13.33% |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 99.09% | 95.97% |
Cash | 0.91% | 3.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 5.10% |
Bharti Hexacom Ltd. | 4.10% |
Axis Bank Ltd. | 3.53% |
Aster DM Healthcare Ltd. | 3.38% |
Godrej Consumer Products Ltd. | 3.16% |
Vishal Mega Mart Ltd. | 2.92% |
Eternal Ltd. | 2.83% |
HDFC Bank Ltd. | 2.74% |
Krishna Institute of Medical Sciences Ltd | 2.72% |
Vijaya Diagnostic Centre Ltd. | 2.71% |
Name | Assets |
---|---|
Info Edge (India) Ltd. | 4.92% |
Eternal Ltd. | 4.21% |
Suzlon Energy Ltd. | 3.54% |
Affle 3I Ltd. | 3.49% |
Ami Organics Ltd. | 3.47% |
Awfis Space Solutions Ltd. | 3.32% |
The Federal Bank Ltd. | 3.26% |
GE Vernova T&D India Ltd. | 3.05% |
PB Fintech Ltd. | 3.04% |
Krishna Institute of Medical Sciences Ltd | 2.87% |
Name | Pankaj Tibrewal | Hardick Bora |
Start Date | 07 Sep 2022 | 25 Jan 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities with a focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy. | The Scheme seeks to achieve long term capital appreciation by investing predominantly in equity and equity related securities of Innovative Companies. |
Launch Date | 07 Sep 2022 | 16 Aug 2023 |
Description
Launch Date